Suchergebnisse - "Liu, Si-Yang"

PubPharm (191)

1

PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901) : A phase 2, randomized, controlled trial

enthalten in: Science bulletin | 2024

von Maggie Liu, S. | Huang, J. | Deng, J. | +18

2

Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer

enthalten in: Thoracic cancer | 2024

von Lin, G. | Wang, Z. | Chu, Q. | +98

3

Impact of preoperative [18F]FDG PET/CT vs. contrast-enhanced CT in the staging and survival of patients with clinical stage I and II non-small cell lung cancer : a 10-year follow-up study

enthalten in: Annals of nuclear medicine | 2024

von Lin, J. | Li, X. | Zhong, W. | +15

4

Adjuvant Therapy-Free Strategy for Stage IB to IIIA Non-Small-Cell Lung Cancer Patients After Radical Resection Based on Longitudinal Undetectable Molecular Residual Disease : Prospective, Multicenter, Single-Arm Study (CTONG 2201)

enthalten in: Clinical lung cancer | 2024

von Zhang, J. | Dong, S. | Gu, W. | +26

5

Rechallenge of immune checkpoint inhibitors in advanced non‐small cell lung cancer

enthalten in: Thoracic Cancer | 2024

von Lin, G. | Wang, Z. | Chu, Q. | +103

6

Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancer

enthalten in: Thoracic cancer | 2023

von Huang, D. | Lin, G. | Chu, Q. | +98

7

Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804) : a multicenter open-label phase II study

enthalten in: Signal transduction and targeted therapy | 2023

von Liu, S. | Dong, S. | Yang, X. | +19

8

A DNAzyme dual-feedback autocatalytic exponential amplification biocircuit for microRNA imaging in living cells

enthalten in: Biosensors & bioelectronics | 2023

von Huang, X. | Li, Z. | Shi, Y. | +9

9

Olfactory Three-Needle Electroacupuncture Improved Synaptic Plasticity and Gut Microbiota of SAMP8 Mice by Stimulating Olfactory Nerve

enthalten in: Chinese journal of integrative medicine | 2023

von Wang, Y. | Zheng, A. | Yang, H. | +6

10

Efficacy, safety and dose selection of AZD3759 in patients with untreated EGFR-mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8) : a multi-center, single-arm, phase 2 trial

enthalten in: EClinicalMedicine | 2023

von Maggie Liu, S. | Dong, X. | Wang, Z. | +23

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[20]